NCT04222647View on ClinicalTrials.gov

Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 27, 2020

Primary Completion Date

August 11, 2020

Study Completion Date

August 11, 2020

Conditions

Vulvovaginal Atrophy

Interventions

DRUG

WO533

Intravaginal application

Trial Locations (1)

Unknown

proDERM Institute for Applied Dermatological Research, Schenefeld

All Listed Sponsors

collaborator

proDERM Institut für Angewandte Dermatologische Forschung GmbH

UNKNOWN

collaborator

Bremer Pharmacovigilance Service GmbH

OTHER

lead

Dr. August Wolff GmbH & Co. KG Arzneimittel

INDUSTRY

NCT04222647 - Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA | Biotech Hunter | Biotech Hunter